<i>NSD1</i>基因新发突变致Sotos综合征患儿1例临床分析并国内相关文献复习

doi:10.3877/cma.j.issn.1673-5250.2022.06.011

目的

探讨NSD1基因新发突变致Sotos综合征患儿的临床特征，并对国内相关研究文献进行复习。

方法

选择2019年9月18日青岛大学附属医院收治的1例Sotos综合征男性患儿(患儿1)为研究对象。回顾性分析其临床资料，采取全外显子组测序及Sanger测序对其致病突变基因位点进行分析，并进行家系验证。本例患儿检出突变位点，于千人基因组数据库、美国国家心肺和血液研究所外显子组测序数据库(ESP6500SI)、外显子组整合数据库(ExAC)进行检索，确定其是否为已报道突变位点。根据美国医学遗传学与基因组学学会(ACMG)制定的《序列变异解释的标准和指南》(以下简称为ACMG指南)，对检出突变致病性进行评级。以"Sotos综合征""脑性巨人症""儿童"为关键词，在万方数据知识服务平台、中国知网等数据库进行文献检索，并对检索文献进行复习。本研究遵循的程序符合青岛大学附属医院伦理委员会规定，并通过该伦理委员会审查、批准(审批文号：QYFYWZLL25663)。

结果

患儿1为3岁10个月男童，由于"生长过快3⁺年"就诊，有过度生长、特殊面容和神经精神发育迟缓等Sotos综合征典型症状；患儿1的男性生殖系统超声结果提示双侧隐睾，骨龄为3.5岁，头颅MRI提示脑实质内未见明显异常信号影，幕上脑白质较少，胼胝体较薄，双侧侧脑室扩张，枕大池增大；患儿1心脏超声、全脊柱正位X射线摄片均未见异常；患儿1 NSD1基因发生c.6007_6009+1delAAAG杂合突变，经Sanger测序验证显示，患儿父母未携带该杂合突变，患儿为新发突变，该突变尚未被千人基因组数据库、ESP6500SI、ExAC等数据库收录。根据ACMG指南，判断该突变为可能致病性突变。文献检索结果：共计检索到20篇国内Sotos综合征患儿相关病例报告，涉及26例Sotos综合征患儿(患儿2~27)。对包括患儿1及患儿2~27的27例该病患儿的分析结果如下。这27例患儿中，①男、女性患儿分别为22、5例。②中位确诊年龄为11个月。③22例患儿报道就诊主诉分别为神经精神发育落后(14例，63.6%)，生长过快(2例，9.1%)，抽搐或其他症状(6例，27.3%)，其余5例患儿未报道就诊主诉；查体发现过度生长为16例(59.3%)，特殊面容为23例(85.2%)，神经精神发育迟缓为27例(100.0%)。④骨龄较实际年龄偏大者为8例，心血管系统发育异常为11例，泌尿生殖系统发育异常为5例，颅脑影像学异常为24例。⑤23例患儿进行基因检测发现，5q35微缺失为10例(43.5%)，NSD1基因突变为12例(52.2%)，NFIX基因突变1例(4.3%)，均为散发病例。

结论

国内报道的Sotos综合征均为散发病例，以NSD1基因突变和5q35微缺失为主；男性患儿居多；均有神经精神发育落后表现，绝大多数有特殊面容和过度生长表现，患儿基因型与表型有较明显相关性。本研究首次报道的NSD1基因c.6007_6009+1delAAAG新发杂合突变丰富了人类NSD1基因突变类型。

关键词: Sotos综合征, NSD1基因, 基因突变, 过度生长, 特殊面容, 发育障碍, 儿童

Objective

To explore the clinical features of children with Sotos syndrome caused by a novel mutation in NSD1 gene and review relevant domestic literature.

Methods

One case of a boy (child No.1) with Sotos syndrome admitted to the Affiliated Hospital of Qingdao University on September 18, 2019 was selected as research subject. The clinical data of this child were retrospectively analyzed, whole exome sequencing and Sanger sequencing were carried out to detect potential pathogenic mutation and family verification. The detected mutation was searched in databases of 1000 Genomes Project, NHLBI GO Exome Sequencing Project(ESP6500SI), and the Exome Aggregation Consortium (ExAC). According to the Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of American College of Medical Genetics and Genomics (ACMG) (hereinafter referred to as the ACMG guideline), pathogenicity of detected gene mutation was comprehensively assessed. With the following key words of " Sotos syndrome" " cerebral gigantism" and "child", domestic literature related to Sotos syndrome was searched from Wanfang Data Knowledge Service Platform and China National Knowledge Infrastructure. The procedure followed in this study was in accordance with the regulations of the Ethics Committee of the Affiliated Hospital of Qingdao University, and was reviewed and approved by the Ethics Committee (Approval No. QYFYWZLL25663).

Results

The boy aged 3 years and 10 months, presented with " overgrowth for more than 3 years". His clinical characteristics were similar to the typical clinical manifestations of Sotos syndrome, including overgrowth, peculiar facial features and neuromental development retardation. Ultrasound of male reproductive system of child No.1 suggested bilateral cryptorchidism, bone age was 3.5 years, his skull MRI suggested no obvious abnormal signal shadow in brain intraparenchymal, less alba in supratentorial brain, thin corpus callosum, bilateral lateral ventricles dilatation, enlarged cisterna magna, without abnormalities in cardiac ultrasound and whole spine orthopantomograph. Child 1 had a heterozygous mutation in NSD1 gene c. 6007_6009+ 1delAAAG, and none of his parents carried this mutation verified by Sanger sequencing, this mutation was a novel mutation, which had not been reported in databases of 1000 Genomes Project, ESP6500SI and ExAC, and was probably pathogenic according to the ACMG guideline. Literature review results: a total of 20 pieces of literature of children with Sotos syndrome case reports were retrieved, involving 26 children with Sotos syndrome (child No.2 to 27), and the results of 27 children with Sotos syndrome (child No.1 to 27) were as follows. ①There were 22 males and 5 females. ②The median age at diagnosis of Sotos syndrome was 11 months. ③A total of 22 children were reported with chief complaint for consultation, including neuromental development retardation (14 cases, 63.6%), overgrowth (2 cases, 9.1%), and convulsions or other symptoms (6 cases, 27.3%), the remaining 5 children did not report a chief complaint for consultation. Physical examination revealed overgrowth in 16 cases (59.3%), peculiar facial features in 23 cases (85.2%), and neuromental development retardation in 27 cases (100.0%). ④The bone age was older than actual age in 8 cases, abnormal development of cardiovascular system in 11 cases, abnormal development of urogenital system in 5 cases, and abnormal cranial imaging in 24 cases. ⑤A total of 23 children accepted gene analysis, including 10 cases (43.5%) with 5q35 microdeletion, 12 cases (52.2%) with NSD1 gene mutation and 1 case (4.3%) with NFIX gene mutation. All of them were sporadic.

Conclusions

In China, all reported children with Sotos syndrome are sporadic, mainly with NSD1 gene mutation and 5q35 microdeletion. The majority of children are male. All children with Sotos syndrome have neuromental development retardation, and most of them have peculiar facial features and overgrowth. There is a significant correlation between genotype and phenotype. The novel heterozygous mutation in NSD1 gene c. 6007_6009+ 1delAAAG reported in this study for the first time enriches the spectrum of genotype in Sotos syndrome.

Key words: Sotos syndrome, NSD1 gene, Gene mutation, Overgrowth, Peculiar facial features, Developmental disabilities, Child

图1 Sotos综合征患儿1(男性，3岁10个月)的相关医学影像学检查结果[图1A：左腕部正位X射线摄片图(骨龄测定)；图1B、1C：分别为头颅MRI检查矢状面、横断面图，提示幕上脑白质较少，胼胝体较薄，双侧侧脑室扩张，枕大池增大]

图2 Sotos综合征患儿1(男性，3岁10个月)及其父母NSD1基因突变位点Sanger测序图(图2A：患儿1的NSD1基因发生c.6007_6009+1delAAAG杂合突变；图2B：患儿1父亲该位点无突变；图2C：患儿1母亲该位点无突变)

图3 Sotos综合征患儿1(男性，3岁10个月)家系图注：Ⅰ表示第1代，Ⅱ表示子代。○表示女性，□表示男性。□1表示患儿1父亲，○2表示患儿1母亲，■1表示患儿1。为先证者

表1 27例Sotos综合征患儿临床表现、相关影像学检查及基因检测结果

患儿编号	年龄	主诉	出生体重(kg)/身长(cm)	就诊时头围(cm)/身高(cm)	心血管系统	骨龄	颅脑影像学	基因检测结果
患儿1	3岁10个月	生长过快3年余	4.3^b/53	50/117.5^c	未见异常	3岁	幕上脑白质较少，胼胝体较薄，双侧脑室扩张，枕大池增大	NSD1c.6007_6009+1delAAAG
患儿2^[6]	12岁	—^a	4.55^b/56	60/172^c	未见异常	14~17岁	右侧脑室扩大	—^a
患儿3^[7]	8岁11个月	口齿不清，学习困难	4.2^b/—^a	56/144^c	心尖区Ⅱ级收缩期杂音	10~14岁	未见异常	—^a
患儿4^[8]	4岁6个月	智力差	4.8^b/60	56/122^c	—^a	4岁6个月	脑室轻度扩大	—^a
患儿5^[9]	1岁2个月	抽搐	3.8/—^a	53/91^c	房间隔缺损或卵圆孔未闭	2~3岁	侧脑室旁白质软化，胼胝体薄	—^a
患儿6^[10]	1岁7个月	头大、智力发育落后	3.15/—^a	52/85	—^a	2~3岁	双侧脑白质血管周围间隙扩张，皮质下髓鞘化不良，胼胝体薄	5q部分缺失(含NSD1基因)
患儿7^[11]	6 h	低血糖6 h	4.03^b/50	38/50	动脉导管及卵圆孔未闭	—^a	脑实质异常信号	5q35.2-35.3(缺失长度为1.97 Mb)
患儿8^[11]	3 d	间断呕吐1 d	4.10^b/49	34/49	卵圆孔未闭	—^a	双侧基底节区和额叶损伤，乳突异常信号	5q35片段缺失
患儿9^[12]	10个月	智力发育落后	3.70/50	50/78.5^c	—^a	—^a	脑室大，脑发育不良	NSD1c.5885T>C
患儿10^[12]	11个月	智力落后，皮肤黑	—^a/—^a	—^a/78.2^c	—^a	—^a	未见异常	NSD1c.5990A>G
患儿11^[12]	6个月	智力发育迟缓	4.80^b/53	47/74^c	—^a	—^a	脑室扩张	NSD1c.4118-4119 insTGACCT
患儿12^[13]	4岁2个月	—^a	—^a/—^a	—^a/—^c	—^a	—^a	未见异常	NFIXc.613C>T
患儿13^[14]	9 d	胎儿宫内窘迫	2.95/51	34/51^c	房间隔缺损，动脉导管未闭	—^a	脑室扩大、大脑萎缩、脑积水	基因突变，无具体结果
患儿14^[15]	7个月	—^a	4.20^b/51	47.5/71	未见异常	2岁	脑室扩大、脑发育不良	5q35.2(缺失长度为1.75 Mb)
患儿15^[15]	10个月	—^a	3.60/50	45.5/48	未见异常	—^a	脑室扩大	NSD1c.1157T>G
患儿16^[15]	1岁1个月	—^a	3.50/53	48/80	未见异常	2~3岁	脑室扩大	NSD1c.1177G>T
患儿17^[16]	8个月	智力发育落后	4.45^b/—^a	—^a/78^c	—^a	—^a	双侧脑室稍扩大	NSD1c.1806delT
患儿18^[17]	8个月	智力发育落后	4.10^b/—^a	48.5/—^a	动脉导管未闭	—^a	胼胝体发育不良，脑室偏大	5q35.2-35.3(缺失长度为1 907 kb)
患儿19^[17]	3岁	智力发育落后	—^a/—^a	52.8/101	动脉导管未闭	—^a	脑室扩张	NSD1c.1262G>A
患儿20^[18]	8个月	行为发育迟缓	4.35^b/—^a	46.5/76^c	室间隔膜部瘤并缺损(多孔型)；卵圆孔未闭	10.8个月	双侧脑室内、室管膜下出血；双侧脑室增宽	5q35.2-35.3(缺失长度为1.54 Mb)
患儿21^[19]	6个月	智力低下	3.24/37.5	—^a/—^a	房间隔缺损、动脉导管未闭	—^a	脑白质发育不良伴髓鞘化迟缓	5q35.2-35.3(缺失长度为5 077 kb)
患儿22^[20]	1岁8个月	行为发育迟缓	3.40/48	51/83	房间隔缺损	1岁	双侧额颞部脑外间隙及侧脑室增宽	5q35.2-35.3(缺失长度为1.96 Mb)
患儿23^[21]	6岁11个月	生长过快5年余	3.40/—^a	58/148.3^c	左心房、心室增大，二尖瓣轻中度反流	8~9岁	幕上脑室增宽，双颞极颅板下、左侧小脑、脑外间隙增宽	NSD1c.5854C>T
患儿24^[22]	2岁4个月	间断抽搐4个月余	—^a/—^a	54.5/100^c	—^a	—^a	胼胝体发育细小	5q35.2-35.3(缺失长度为1. 797 Mb)
患儿25^[23]	5个月	智力发育迟滞	3.99/—^a	49.2/71^c	未见异常	—^a	双侧脑室体部异常信号	NSD1c.5791T>C
患儿26^[24]	9 d	纳差9 d	4.2^a/53	37/53	—^a	—^a	左侧脑室体部旁软化灶、双侧脑室稍增宽	5q35.2-q35.3(缺失长度为2.02 Mb)
患儿27^[25]	1岁6个月	自幼智力发育落后	4.6^b/—^a	51/88^c	未见异常	—^a	双侧脑室明显扩张	NSD1c.4378+1_c.4378+4delGTGA

表1 27例Sotos综合征患儿临床表现、相关影像学检查及基因检测结果

患儿编号	年龄	主诉	出生体重(kg)/身长(cm)	就诊时头围(cm)/身高(cm)	心血管系统	骨龄	颅脑影像学	基因检测结果
患儿1	3岁10个月	生长过快3年余	4.3^b/53	50/117.5^c	未见异常	3岁	幕上脑白质较少，胼胝体较薄，双侧脑室扩张，枕大池增大	NSD1c.6007_6009+1delAAAG
患儿2^[6]	12岁	—^a	4.55^b/56	60/172^c	未见异常	14~17岁	右侧脑室扩大	—^a
患儿3^[7]	8岁11个月	口齿不清，学习困难	4.2^b/—^a	56/144^c	心尖区Ⅱ级收缩期杂音	10~14岁	未见异常	—^a
患儿4^[8]	4岁6个月	智力差	4.8^b/60	56/122^c	—^a	4岁6个月	脑室轻度扩大	—^a
患儿5^[9]	1岁2个月	抽搐	3.8/—^a	53/91^c	房间隔缺损或卵圆孔未闭	2~3岁	侧脑室旁白质软化，胼胝体薄	—^a
患儿6^[10]	1岁7个月	头大、智力发育落后	3.15/—^a	52/85	—^a	2~3岁	双侧脑白质血管周围间隙扩张，皮质下髓鞘化不良，胼胝体薄	5q部分缺失(含NSD1基因)
患儿7^[11]	6 h	低血糖6 h	4.03^b/50	38/50	动脉导管及卵圆孔未闭	—^a	脑实质异常信号	5q35.2-35.3(缺失长度为1.97 Mb)
患儿8^[11]	3 d	间断呕吐1 d	4.10^b/49	34/49	卵圆孔未闭	—^a	双侧基底节区和额叶损伤，乳突异常信号	5q35片段缺失
患儿9^[12]	10个月	智力发育落后	3.70/50	50/78.5^c	—^a	—^a	脑室大，脑发育不良	NSD1c.5885T>C
患儿10^[12]	11个月	智力落后，皮肤黑	—^a/—^a	—^a/78.2^c	—^a	—^a	未见异常	NSD1c.5990A>G
患儿11^[12]	6个月	智力发育迟缓	4.80^b/53	47/74^c	—^a	—^a	脑室扩张	NSD1c.4118-4119 insTGACCT
患儿12^[13]	4岁2个月	—^a	—^a/—^a	—^a/—^c	—^a	—^a	未见异常	NFIXc.613C>T
患儿13^[14]	9 d	胎儿宫内窘迫	2.95/51	34/51^c	房间隔缺损，动脉导管未闭	—^a	脑室扩大、大脑萎缩、脑积水	基因突变，无具体结果
患儿14^[15]	7个月	—^a	4.20^b/51	47.5/71	未见异常	2岁	脑室扩大、脑发育不良	5q35.2(缺失长度为1.75 Mb)
患儿15^[15]	10个月	—^a	3.60/50	45.5/48	未见异常	—^a	脑室扩大	NSD1c.1157T>G
患儿16^[15]	1岁1个月	—^a	3.50/53	48/80	未见异常	2~3岁	脑室扩大	NSD1c.1177G>T
患儿17^[16]	8个月	智力发育落后	4.45^b/—^a	—^a/78^c	—^a	—^a	双侧脑室稍扩大	NSD1c.1806delT
患儿18^[17]	8个月	智力发育落后	4.10^b/—^a	48.5/—^a	动脉导管未闭	—^a	胼胝体发育不良，脑室偏大	5q35.2-35.3(缺失长度为1 907 kb)
患儿19^[17]	3岁	智力发育落后	—^a/—^a	52.8/101	动脉导管未闭	—^a	脑室扩张	NSD1c.1262G>A
患儿20^[18]	8个月	行为发育迟缓	4.35^b/—^a	46.5/76^c	室间隔膜部瘤并缺损(多孔型)；卵圆孔未闭	10.8个月	双侧脑室内、室管膜下出血；双侧脑室增宽	5q35.2-35.3(缺失长度为1.54 Mb)
患儿21^[19]	6个月	智力低下	3.24/37.5	—^a/—^a	房间隔缺损、动脉导管未闭	—^a	脑白质发育不良伴髓鞘化迟缓	5q35.2-35.3(缺失长度为5 077 kb)
患儿22^[20]	1岁8个月	行为发育迟缓	3.40/48	51/83	房间隔缺损	1岁	双侧额颞部脑外间隙及侧脑室增宽	5q35.2-35.3(缺失长度为1.96 Mb)
患儿23^[21]	6岁11个月	生长过快5年余	3.40/—^a	58/148.3^c	左心房、心室增大，二尖瓣轻中度反流	8~9岁	幕上脑室增宽，双颞极颅板下、左侧小脑、脑外间隙增宽	NSD1c.5854C>T
患儿24^[22]	2岁4个月	间断抽搐4个月余	—^a/—^a	54.5/100^c	—^a	—^a	胼胝体发育细小	5q35.2-35.3(缺失长度为1. 797 Mb)
患儿25^[23]	5个月	智力发育迟滞	3.99/—^a	49.2/71^c	未见异常	—^a	双侧脑室体部异常信号	NSD1c.5791T>C
患儿26^[24]	9 d	纳差9 d	4.2^a/53	37/53	—^a	—^a	左侧脑室体部旁软化灶、双侧脑室稍增宽	5q35.2-q35.3(缺失长度为2.02 Mb)
患儿27^[25]	1岁6个月	自幼智力发育落后	4.6^b/—^a	51/88^c	未见异常	—^a	双侧脑室明显扩张	NSD1c.4378+1_c.4378+4delGTGA

[1]	Tatton-brown K, Douglas J, Coleman K, et al. Genotype-phenotype associations in Sotos syndrome: an analysis of 266 individuals with NSD1 aberrations[J]. Am J Hum Genet, 2005, 77(2): 193-204. DOI: 10.1086/432082.
[2]	Faravelli F. NSD1 mutations in Sotos syndrome[J]. Am J Med Genet C Semin Med Genet, 2005, 137C(1): 24-31. DOI: 10.1002/ajmg.c.30061.
[3]	Kurotaki N, Imaizumi K, Harada N, et al. Haploinsufficiency of NSD1 causes Sotos syndrome[J]. Nat Genet, 2002, 30(4): 365-366. DOI: 10.1038/ng863.
[4]	Tatton-Brown K, Cole T, Rahman N. Sotos syndrome[M]// Adam MP, Everman DB, Mirzaa GM, et al. GeneReviews^®. Seattle (WA): University of Washington, 2012.
[5]	Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology[J]. Genet Med, 2015, 17(5): 405-424. DOI: 10.1038/gim.2015.30.
[6]	王秉道，沈健. 脑性巨人症一例报告[J]. 上海医学，1982, 5(6): 366.
[7]	郑师方，李雅嘉. Sotos综合征一例报告[J]. 中国优生优育，1992, 3(2): 94-95.
[8]	李永库，王贞，文香淑，等. 脑性巨人症一例[J]. 中华儿科杂志，2001, 39(12): 766. DOI: 10.3760/j.issn:0578-1310.2001.12.021.
[9]	孙嫱，沈颖，刘敏，等. Sotos综合征1例并文献复习[J]. 实用儿科临床杂志，2009, 24(2): 155-156. DOI: 10.3760/cma.j.issn.2095-428X.2009.02.130.
[10]	王旭. Sotos综合征NSD1基因缺失突变1例报告并文献复习[J]. 中国实用儿科杂志，2013, 28(6): 461-463.
[11]	孙碧君，杨琳，梅枚，等. 新生儿Sotos综合征二例报道及文献复习[J]. 中华围产医学杂志，2015, 18(2): 127-130. DOI: 10.3760/cma.j.issn.1007-9408.2015.02.009.
[12]	康路路，刘晓青，张惠文，等. 3例Sotos综合征的基因型与临床表现分析[J]. 上海交通大学学报(医学版), 2016, 36(8): 1165-1170. DOI: 10.3969/j.issn.1674-8115.2016.08.011.
[13]	延会芳，冀浩然，杨晓平，等. 原发性智力障碍/发育迟缓患儿临床及遗传学分析[J]. 中华实用儿科临床杂志，2016, 31(19): 1475-1479. DOI: 10.3760/cma.j.issn.2095-428X.2016.19.010.
[14]	陈黎丽. 基因突变Sotos综合征1型一例报告[J]. 中国优生与遗传杂志，2017, 25(5): 119, 68. DOI: 10.13404/j.cnki.cjbhh.2017.05.054.
[15]	赵敏. Sotos综合征的临床表型及遗传学分析[J]. 中国当代儿科杂志，2018, 20(6): 481-484. DOI: 10.7499/j.issn.1008-8830.2018.06.010.
[16]	张慧珍，李赵荣. Sotos综合征NSD1基因移码突变1例报告[J]. 中国保健营养，2018, 28(26): 344.
[17]	陆勇刚，胥雨菲，姚如恩，等. Sotos综合征2例报道及文献复习[J]. 检验医学，2018, 33(4): 353-358. DOI: 10.3969/j.issn.1673-8640.2018.04.018.
[18]	孙永康，都修波，姜娴荷. Sotos综合征1例并文献复习[J]. 实用医药杂志，2019, 36(4): 344-347. DOI: 10.14172/j.issn1671-4008.2019.04.021.
[19]	罗玉琴，孙义锡，钱叶青，等. Sotos综合征患儿的遗传学分析[J]. 中华医学遗传学杂志，2020, 37(2): 127-130. DOI: 10.3760/cma.j.issn.1003-9406.2020.02.006.
[20]	柯钟灵，王勇，陈珊. 1例Sotos综合征临床特点及遗传学分析[J]. 福建医科大学学报，2021, 55(3): 262-265, 268. DOI: 10.3969/j.issn.1672-4194.2021.03.018.
[21]	郑洪雪，陈瑶，殷丽萍，等. Sotos综合征患儿临床特征及基因变异分析[J]. 检验医学，2021, 36(2): 130-134. DOI: 10.3969/j.issn.1673-8640.2021.02.003.
[22]	赵永恒，牛悦，张童，等. 1例疑似Sotos综合征的患儿及其父母基因检测分析[J]. 山东医药，2021, 61(18): 61-64. DOI: 10.3969/j.issn.1002-266X.2021.18.015.
[23]	候颖慧，姜红. SOTOS综合征NSD1基因新发错义突变1例并文献复习[J]. 精准医学杂志，2021, 36(1): 59-62, 67. DOI: 10.13362/j.jpmed.202101013.
[24]	王娴，万致婷. 新生儿Sotos综合征1例报道[J]. 湖北科技学院学报(医学版), 2021, 35(3): 258-260,封3. DOI: 10.16751/j.cnki.2095-4646.2021.03.0258.
[25]	石凯丽，李瑞芳，赵惠敏，等. Sotos综合征NSD1基因新位点变异一例并文献复习[J/OL]. 中华临床医师杂志(电子版), 2020, 14(12): 1042-1044. DOI: 10.3877/cma.j.issn.1674-0785.2020.12.018.
[26]	Sotos JF, Dodge PR, Muirhead D, et al. A syndrome of excessively rapid growth and acromegalic features and a nonprogressive neurologic disorder[J]. N Engl J Med，1964, 271: 109-116 .DOI: 10.1056/NEJM196407162710301.
[27]	Sotos JF. Sotos syndrome 1 and 2[J]. Pediatr Endocrinol Rev, 2014, 12(1): 2-16.
[28]	Tatton-Brown K, Rahman N. Sotos syndrome[J]. Eur J Hum Genet, 2007, 15(3): 264-271. DOI: 10.1038/sj.ejhg.5201686.
[29]	Niikawa N. Molecular basis of Sotos syndrome[J]. Horm Res, 2004, 62(Suppl 3): 60-65. DOI: 10.1159/000080501.
[30]	The Human Protein Atlas[EB/OL]. (2021-07-13)[2022-06-12]. URL
[31]	Machida M, Katoh H, Miyake A, et al. The association of scoliosis and NSD1 gene deletion in Sotos syndrome patients[J]. Spine (Phila Pa 1976), 2021, 46(13): E726-E733. DOI: 10.1097/BRS.0000000000003879.
[32]	Tong TM, Hau EW, Lo IF, et al. Spectrum of NSD1 gene mutations in southern Chinese patients with Sotos syndrome[J]. Chin Med J (Engl), 2005, 118(18): 1499-1506.
[33]	Foster A, Zachariou A, Loveday C, et al. The phenotype of Sotos syndrome in adulthood: a review of 44 individuals[J]. Am J Med Genet C Semin Med Genet, 2019, 181(4): 502-508. DOI: 10.1002/ajmg.c.31738.
[34]	Castro MAA, Dos santos JHV, Honjo RS, et al. Twenty-year follow-up of the facial phenotype of Brazilian patients with Sotos syndrome[J]. Am J Med Genet A, 2021, 185(12): 3916-3923. DOI: 10.1002/ajmg.a.62454.
[35]	Gusmão Melo D, Pina-neto JM, Acosta AX, et al. Neuroimaging and echocardiographic findings in Sotos syndrome[J]. Am J Med Genet, 2000, 90(5): 432-434.
[36]	Schaefer GB, Bodensteiner JB, Buehler BA, et al. The neuroimaging findings in Sotos syndrome[J]. Am J Med Genet, 1997, 68(4): 462-465. DOI: 10.1002/(sici)1096-8628(19970211)68:4<462::aid-ajmg18>3.0.co;2-q.
[37]	Visser R, Landman EBM, Goeman J, et al. Sotos syndrome is associated with deregulation of the MAPK/ERK-signaling pathway[J]. PLoS One, 2012, 7(11): e49229. DOI: 10.1371/journal.pone.0049229.
[38]	Cao B, Peng Y, Song W, et al. Pediatric continuous reference intervals of serum insulin-like growth factor 1 levels in a healthy chinese children population - based on PRINCE study[J]. Endocr Pract, 2022, 28(7): 696-702. DOI: 10.1016/j.eprac.2022.04.004.
[39]	Wit JM, Beemer FA, Barth PG, et al. Cerebral gigantism (Sotos syndrome). Compiled data of 22 cases. Analysis of clinical features, growth and plasma somatomedin[J]. Eur J Pediatr, 1985, 144(2): 131-140. DOI: 10.1007/BF00451898.
[40]	Manor J, Lalani SR. Overgrowth syndromes-evaluation, diagnosis, and management[J]. Front Pediatr, 2020, 8: 574857. DOI: 10.3389/fped.2020.574857.
[41]	Tauchmann S, Schwaller J. NSD1: a lysine methyltransferase between developmental disorders and Cancer[J]. Life (Basel), 2021, 11(9): 877. DOI: 10.3390/life1109087.
[42]	Villani A, Greer MLC, Kalish JM, et al. Recommendations for cancer surveillance in individuals with RASopathies and other rare genetic conditions with increased cancer risk[J]. Clin Cancer Res, 2017, 23(12): e83-e90. DOI: 10.1002/ajmg.c.31738.
[43]	Laccetta G, Moscuzza F, Michelucci A, et al. A novel missense mutation of the NSD1 gene associated with overgrowth in three generations of an italian family: case report, differential diagnosis, and review of mutations of NSD1 gene in familial sotos syndrome[J]. Front Pediatr, 2017, 5: 236. DOI: 10.3389/fped.2017.00236.
[44]	Fryssira H, Drossatou P, Sklavou R, et al. Two cases of Sotos syndrome with novel mutations of the NSD1 gene[J]. Genet Couns, 2010, 21(1)：53-59.
[45]	Mencarelli A, Prontera P, Mencarelli A, et al. Expanding the clinical spectrum of Sotos syndrome in a patient with the new " c.[5867T>A]+[＝]" ；" p.[Leu1956Gln]+[＝]" NSD1Missense Mutation and Complex Skin Hamartoma[J]. Int J Mol Sci, 2018, 19(10): 3189. DOI: 10.3390/ijms19103189.
[46]	Gilaberte Y, Ferrer-lozano M, Oliván MJ, et al. Multiple giant pilomatricoma in familial Sotos syndrome[J]. Pediatr Dermatol, 2010, 25(1): 122-125. DOI: 10.1111/j.1525-1470.2007.00602.x.
[47]	Bou-Assi E, Bonniaud B, Grimaldi M, et al. Neonatal cutis laxa and hypertrichosis lanuginosa in Sotos syndrome[J]. Pediatr Dermatol, 2016, 33(6): e351-e352. DOI: 10.1111/pde.12969.
[48]	CortèsSaladelafont E, AriasSáez K, Estebanoliva D, et al. Sotos syndrome: a novel nonsense mutation in NSD1 gene, presenting with neonatal cutis laxa[J]. An Pediatr (Barc), 2011, 75(2): 129-133. DOI: 10.1016/j.anpedi.2011.02.018.

[1]	陶宏宇, 叶菁菁, 俞劲, 杨秀珍, 钱晶晶, 徐彬, 徐玮泽, 舒强. 右心声学造影在儿童右向左分流相关疾病中的评估价值[J/OL]. 中华医学超声杂志（电子版）, 2024, 21(10): 959-965.
[2]	刘琴, 刘瀚旻, 谢亮. 基质金属蛋白酶在儿童哮喘发生机制中作用的研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 564-568.
[3]	向韵, 卢游, 杨凡. 全氟及多氟烷基化合物暴露与儿童肥胖症相关性研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 569-574.
[4]	刘静, 王燕妮, 王继萍. 儿童毛发移植应用前景及病例讨论[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(04): 368-368.
[5]	郑宝英, 黄小兰, 贾楠, 朱春梅. 儿童难治性肺炎支原体肺炎早期预警指标[J/OL]. 中华实验和临床感染病杂志(电子版), 2024, 18(04): 215-221.
[6]	刘冉佳, 崔向丽, 周效竹, 曲伟, 朱志军. 儿童肝移植受者健康相关生存质量评价的荟萃分析[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 302-309.
[7]	丁荷蓓, 王珣, 陈为国. 七氟烷吸入麻醉与异丙酚静脉麻醉在儿童腹股沟斜疝手术中的应用比较[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(05): 570-574.
[8]	刘文竹, 唐窈, 刘付臣. 诱导多潜能干细胞在神经肌肉疾病研究中的应用进展[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(06): 367-373.
[9]	中华医学会器官移植学分会, 中华医学会外科学分会外科手术学学组, 中华医学会外科学分会移植学组, 华南劈离式肝移植联盟. 劈离式供肝儿童肝移植中国临床操作指南[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 593-601.
[10]	刘军, 丘文静, 孙方昊, 李松盈, 易述红, 傅斌生, 杨扬, 罗慧. 在体与离体劈离式肝移植在儿童肝移植中的应用比较[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 688-693.
[11]	张琛, 秦鸣, 董娟, 陈玉龙. 超声检查对儿童肠扭转缺血性改变的诊断价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 565-568.
[12]	李玺, 蔡芸莹, 张永红, 苏恒. 假性软骨发育不全合并1型糖尿病一例[J/OL]. 中华临床医师杂志(电子版), 2024, 18(05): 518-520.
[13]	张成惠, 闫中瑞, 盛志强, 袁嫣然. 脑肌酸缺乏症诊断与治疗研究进展[J/OL]. 中华诊断学电子杂志, 2024, 12(04): 270-275.
[14]	陈晓胜, 何佳, 刘方, 吴蕊, 杨海涛, 樊晓寒. 直立倾斜试验诱发31 秒心脏停搏的植入心脏起搏器儿童一例并文献复习[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(05): 488-494.
[15]	曹亚丽, 高雨萌, 张英谦, 李博, 杜军保, 金红芳. 儿童坐位不耐受的临床进展[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(05): 510-515.

阅读次数

全文

摘要

选择文件类型/文献管理软件名称

选择包含的内容

Sotos syndeome with a novel mutation in NSD1 gene: a case report and domestic literature review

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

Sotos syndeome with a novel mutation in NSD1 gene: a case report and domestic literature review